Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiovascular Disease
Video: the Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test
May 12th, 2008
Interleukin Genetics, Inc. (AMEX:ILI), announced publication of the results of clinical studies that support the company's Heart Health Genetic Test to assess cardiovascular risk. The article, titled, "IL1B Gene Promoter Haplotype Pairs Predict Clinical Levels of Interleukin-1beta and C-reactive Protein," was published in the journal Human Genetics (123:387-398; May 2008) and further confirms prior studies associating variations in the Interleukin 1B (IL1B) gene with the inflammatory response. To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/ilgenetics/32863/ Sir Gordon W. Duff, M.D., Ph.D., one of the pioneers in the...
Source: Biotech Business Week (2008-05-12)
|
